|
Description:
|
|
Lung Cancer Considered host Dr. Stephen Liu and two distinguished thoracic oncologists review the highlights from the recently completed ESMO Asia 2024 meeting, held in Singapore. The episode covers a number of trials, including an update on FLAURA2, TROPION-Lung01 and TROPION-Lung05, ALESIA, and PACIFIC 5.
Guest: Dr. Misako Nagasaka, Associate Professor from the University of California, Irvine
Guest: by Dr. Molly Li, Clinical Assistant Professor from Chinese University of Hong Kong. |